Skip to content

Randomized Control Trial To Determine The Use And Safety of Hypertonic Saline Gargling In Acute Upper Respiratory Tract Infections in Children

Efficacy And Safety Of Hypertonic Saline Gargling In Children With An Acute Upper Respiratory Tract Infection: A Pilot, Randomized Controlled Trial - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059420
Enrollment
90
Registered
2023-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Hypertonic saline gargling: This will be the intervention group or Group A Patients will be made to gargle with 3% hypertonic saline, more than 3 times daily, for five days, or until c

Sponsors

Post Graduate Institute of Medical Education & Research, Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children from 4-12 years of age with upper respiratory tract infection (as defined below), who are capable of gargling, to be determined by demonstration in the OPD. Definition of URTI: “Presence of at least two respiratory symptoms such as nasal congestion (runny nose, stuffy nose), cough, sore throat OR a respiratory symptom plus at least one systemic symptom (Low energy/tired, muscle aches/pains, headache, fever =38°C) ?.

Exclusion criteria

Exclusion criteria: 1. Children who are unable to gargle. 2. SARS-CoV2 PCR positive children 3. Children with: a. Known pre-existing chronic respiratory disease viz. cystic fibrosis, pulmonary or extrapulmonary tuberculosis, bronchiectasis. b. Allergic rhinitis c. Known aero-digestive disorders such as gastro-esophageal reflux disease. d. Immunosuppression for any reason. e. Known primary or secondary immune deficiency. 4. Children taking part in any other trials.

Design outcomes

Primary

MeasureTime frame
Time for resolution of URTI.Timepoint: This will be defined as the time taken (in days) for resolution of all symptoms of the URI episode from the time of randomization Severity of illness will be assessed by the WURSSK score that will be scored by the parents/children on a daily basis. Score will be recorded at enrollment upto the time of resolution or 14 days whichever is earlier Resolution is defined as the WURSSK score being 0

Secondary

MeasureTime frame
Discontinuation of study medicationsTimepoint: subjective as per reasons stated by patient within 14 days or resolution of symptoms;Need for contacting healthcare professionalTimepoint: Number of times contacted within 14 days or resolution, whichever earlier;Number of days lost from schoolTimepoint: Within 14 days or upto resolution of symptoms;Number of days lost from work for parentsTimepoint: days lost within 14 days or upto resolution of symptoms of child;Parental assessment of severityTimepoint: Based on WURSSK score, 14 days or resolution whichever earlier;Perceived adverse eventsTimepoint: Number & type of adverse events within 14 days or resolution, whichever earlier;Resolution of symptomsTimepoint: 14 days or resolution whichever earlier

Countries

India

Contacts

Public ContactDr. Joseph L Mathew

Postgraduate Institute of Medical Education and Research, Chandigarh

dr.joseph.l.mathew@gmail.com7087008357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026